Cytonus Therapeutics
Carlsbad
About Cytonus Therapeutics
Cytonus Therapeutics is a biotechnology company focused on developing novel therapeutic solutions using its proprietary drug delivery platform. The company’s technology enables the targeted delivery of biologic agents to specific tissues, enhancing the efficacy of treatments for a variety of conditions, including cancer and autoimmune diseases. Cytonus’s platform leverages the natural properties of cells to transport therapeutic molecules, allowing for more precise and controlled treatment delivery. The company’s pipeline includes products designed to improve the effectiveness of existing therapies while minimizing side effects. By advancing drug delivery technologies, Cytonus aims to enhance treatment outcomes and patient care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: cytonus.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cytonus-therapeutics-47109 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.